1 unknown. 1 Phase 4.
| Phase | Trials | Status |
|---|---|---|
| Phase 4 | 1 | Unknown 1 |
Follow Xu Li: new trials by email
Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.
| Trial | Phase | Status | Sponsor | Enrollment | Start | Updated |
|---|---|---|---|---|---|---|
| Nafamostat Mesilate in the Treatment of Severe Infection-associated Coagulopathy Nafamostat mesilate, 5% glucose - Sepsis, Sepsis-induced Coagulopathy | Phase 4 | Unknown | Xu Li | 778 | 2023-10-01 | 2023-10-12 |
Sepsis (1)
Glucose (1) · nafamostat (1)